» Articles » PMID: 37149591

Role of Adiponectin, Resistin and Monocyte Chemo-attractant Protein-1 in Overweight/obese Asthma Phenotype in Children

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2023 May 6
PMID 37149591
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Asthma is a chronic inflammatory disorder of the airways with diverse overlapping pathologies and phenotypes contributing to a significant heterogeneity in clinical manifestations. Obesity may modify asthma risk, phenotype, and prognosis. A suggested mechanism linking obesity and asthma is through systemic inflammation. Adipokines secreted by adipose tissue were suggested to provide a link between obesity and asthma.

Objective: To have an understanding for the contribution of adiponectin, resistin and MCP-1 to development of distinct asthma phenotype in overweight/obese children through assessment of their serum level and correlation to pulmonary function tests.

Subjects And Methods: The study included 29 normal weight asthmatics, 23 overweight/obese asthmatic children and 30 controls. All cases were subjected to detailed history taking, thorough examination and pulmonary function tests. Serum adiponectin, resistin, MCP-1 and IgE were assessed to all recruited subjects.

Results: Adiponectin level was significantly higher in overweight/obese asthmatics (24900 ± 1600 ng/ml) compared to normal weight asthmatics (21700 ± 1700 ng/ml) and control (23000 ± 3200 ng/ml), (p < 0.001 & 0.051 respectively). Normal weight asthmatics had significantly lower adiponectin level than control, (p = 0.039). A significant low level of MCP-1 in overweight/obese asthmatics (149.5 (20-545) ng/L) compared to control (175 (28 -1123.5) ng/L), p = 0.037. No significant difference was found regarding resistin. Normal weight asthmatics had significantly lower FEV% and FVC% compared to overweight/obese asthmatics (p = 0.036, 0.016 respectively). A significant positive correlation was found between (FEV1%, FVC) and BMI in normal weight asthmatics (P = 0.01, < 0.01 respectively) and a significant negative correlation between PEF and BMI (-0.42, p = 0.05) in obese/overweight asthmatics. Resistin/adiponectin ratio was not affected by sex, degree of asthma severity or level of asthma control in either normal weight or overweight/obese asthmatic.

Conclusion: This work could suggest that adiponectin may play a role in overweight/obese asthma phenotype where it is possible to have a dual action (pro & anti- inflammatory). It seems that resistin had no role in asthma pathogenesis.

References
1.
Ross K, Storfer-Isser A, Hart M, Kibler A, Rueschman M, Rosen C . Sleep-disordered breathing is associated with asthma severity in children. J Pediatr. 2011; 160(5):736-42. PMC: 3975834. DOI: 10.1016/j.jpeds.2011.10.008. View

2.
Giuffrida M, Valero N, Mosquera J, Alvarez De Mon M, Chacin B, Espina L . Increased cytokine/chemokines in serum from asthmatic and non-asthmatic patients with viral respiratory infection. Influenza Other Respir Viruses. 2013; 8(1):116-22. PMC: 4177805. DOI: 10.1111/irv.12155. View

3.
de Lima Azambuja R, da Costa Santos Azambuja L, Costa C, Rufino R . Adiponectin in Asthma and Obesity: Protective Agent or Risk Factor for More Severe Disease?. Lung. 2015; 193(5):749-55. DOI: 10.1007/s00408-015-9793-8. View

4.
Wadsworth S, Sin D, Dorscheid D . Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy. 2011; 4:77-86. PMC: 3140298. DOI: 10.2147/JAA.S15081. View

5.
Reyes-Angel J, Kaviany P, Rastogi D, Forno E . Obesity-related asthma in children and adolescents. Lancet Child Adolesc Health. 2022; 6(10):713-724. DOI: 10.1016/S2352-4642(22)00185-7. View